TWST
Income statement / Annual
Last year (2024), Twist Bioscience Corporation's total revenue was $312.97 M,
an increase of 27.69% from the previous year.
In 2024, Twist Bioscience Corporation's net income was -$208.73 M.
See Twist Bioscience Corporation,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
09/30/2024 |
09/30/2023 |
09/30/2022 |
09/30/2021 |
09/30/2020 |
09/30/2019 |
09/30/2018 |
09/30/2017 |
09/30/2016 |
| Operating Revenue |
$312.97 M |
$245.11 M |
$203.57 M |
$132.33 M |
$90.10 M |
$54.39 M |
$25.43 M |
$10.77 M |
$2.27 M |
| Cost of Revenue |
$179.63 M
|
$155.38 M
|
$119.33 M
|
$80.62 M
|
$61.41 M
|
$47.43 M
|
$32.19 M
|
$24.02 M
|
$9.42 M
|
| Gross Profit |
$133.35 M
|
$89.73 M
|
$84.24 M
|
$51.71 M
|
$28.69 M
|
$6.96 M
|
-$6.76 M
|
-$13.25 M
|
-$7.15 M
|
| Gross Profit Ratio |
0.43
|
0.37
|
0.41
|
0.39
|
0.32
|
0.13
|
-0.27
|
-1.23
|
-3.15
|
| Research and Development Expenses |
$90.85 M
|
$106.89 M
|
$120.31 M
|
$69.07 M
|
$43.01 M
|
$35.68 M
|
$20.35 M
|
$19.17 M
|
$18.23 M
|
| General & Administrative Expenses |
$0.00
|
$186.84 M
|
$210.55 M
|
$133.40 M
|
$102.07 M
|
$78.83 M
|
$42.55 M
|
$25.96 M
|
$18.07 M
|
| Selling & Marketing Expenses |
$0.00
|
$2.90 M
|
$2.40 M
|
$2.50 M
|
$1.20 M
|
$1.30 M
|
$900,000.00
|
$100,000.00
|
$200,000.00
|
| Selling, General & Administrative Expenses |
$218.40 M
|
$189.74 M
|
$212.95 M
|
$135.90 M
|
$103.27 M
|
$80.13 M
|
$43.45 M
|
$26.06 M
|
$18.27 M
|
| Other Expenses |
$44.93 M
|
$10.26 M
|
-$1.09 M
|
-$1.37 M
|
-$182,000.00
|
-$265,000.00
|
-$121,000.00
|
-$55,000.00
|
$73,000.00
|
| Operating Expenses |
$354.18 M
|
$306.89 M
|
$333.26 M
|
$204.97 M
|
$146.27 M
|
$115.81 M
|
$63.80 M
|
$45.23 M
|
$36.50 M
|
| Cost And Expenses |
$533.81 M
|
$462.27 M
|
$452.59 M
|
$285.59 M
|
$207.68 M
|
$163.24 M
|
$95.99 M
|
$69.25 M
|
$45.93 M
|
| Interest Income |
$15.34 M
|
$14.37 M
|
$3.06 M
|
$435,000.00
|
$1.50 M
|
$3.03 M
|
$999,000.00
|
$412,000.00
|
$241,000.00
|
| Interest Expense |
$29,000.00
|
$5,000.00
|
$80,000.00
|
$367,000.00
|
$787,000.00
|
$1.29 M
|
$1.31 M
|
$905,000.00
|
$746,000.00
|
| Depreciation & Amortization |
$31.43 M
|
$29.31 M
|
$36.64 M
|
$11.99 M
|
$6.68 M
|
$6.31 M
|
$5.73 M
|
$5.02 M
|
$4.23 M
|
| EBITDA |
-$176.71 M |
-$174.15 M |
-$191.55 M |
-$143.91 M |
-$132.09 M |
-$99.77 M |
-$63.95 M |
-$53.10 M |
-$39.11 M |
| EBITDA Ratio |
-0.56
|
-0.71
|
-1.21
|
-1.17
|
-1.29
|
-1.95
|
-2.52
|
-4.93
|
-17.24
|
| Operating Income Ratio |
-0.71
|
-0.89
|
-1.22
|
-1.16
|
-1.3
|
-2
|
-2.77
|
-5.43
|
-19.24
|
| Total Other Income/Expenses Net |
$12.67 M
|
$13.69 M
|
$6.50 M
|
-$1.30 M
|
$530,000.00
|
$1.47 M
|
-$435,000.00
|
-$548,000.00
|
-$432,000.00
|
| Income Before Tax |
-$208.17 M
|
-$203.47 M
|
-$228.27 M
|
-$154.03 M
|
-$139.55 M
|
-$107.38 M
|
-$70.99 M
|
-$59.03 M
|
-$44.09 M
|
| Income Before Tax Ratio |
-0.67
|
-0.83
|
-1.12
|
-1.16
|
-1.55
|
-1.97
|
-2.79
|
-5.48
|
-19.43
|
| Income Tax Expense |
$560,000.00
|
$1.15 M
|
-$10.41 M
|
-$1.93 M
|
$382,000.00
|
$292,000.00
|
$242,000.00
|
$280,000.00
|
$819,000.00
|
| Net Income |
-$208.73 M
|
-$204.62 M
|
-$217.86 M
|
-$152.10 M
|
-$139.93 M
|
-$107.67 M
|
-$71.24 M
|
-$59.31 M
|
-$44.09 M
|
| Net Income Ratio |
-0.67
|
-0.83
|
-1.07
|
-1.15
|
-1.55
|
-1.98
|
-2.8
|
-5.51
|
-19.43
|
| EPS |
-3.6 |
-3.6 |
-4.04 |
-3.15 |
-3.57 |
-3.92 |
-2.68 |
-3.16 |
-2.35 |
| EPS Diluted |
-3.6 |
-3.6 |
-4.04 |
-3.15 |
-3.57 |
-3.92 |
-2.68 |
-3.16 |
-2.35 |
| Weighted Average Shares Out |
$58.02 M
|
$56.89 M
|
$53.89 M
|
$48.25 M
|
$39.19 M
|
$27.46 M
|
$26.61 M
|
$18.78 M
|
$18.78 M
|
| Weighted Average Shares Out Diluted |
$58.02 M
|
$56.89 M
|
$53.89 M
|
$48.25 M
|
$39.19 M
|
$27.46 M
|
$26.61 M
|
$18.78 M
|
$18.78 M
|
| Link |
|
|
|
|
|
|
|
|
|
